David Linetsky - 01 Oct 2020 Form 4/A - Amendment Insider Report for Phreesia, Inc. (PHR)

Role
SVP, Life Sciences
Signature
/s/ Allison Hoffman by Power of Attorney for David Linetsky
Issuer symbol
PHR
Transactions as of
01 Oct 2020
Net transactions value
$0
Form type
4/A - Amendment
Filing time
10 Sep 2021, 17:16:49 UTC
Date Of Original Report
05 Oct 2020
Previous filing
10 Sep 2021
Next filing
27 Aug 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PHR Stock Option (Right to Buy) Options Exercise $0 -1,377 -4.4% $0.000000 30,003 01 Oct 2020 Common Stock 1,377 $4.71 Direct F1, F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 25% of this option shall vest and become exercisable on August 7, 2019, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.
F3 The original Form 4 filed on October 5, 2020, is being amended by this Form 4 amendment to correct the vesting schedule of this grant.
F4 The original Form 4 filed on October 5, 2020, is being amended by this Form 4 amendment to correct the number of derivative securities beneficially owned by the Reporting Person after the reported transaction.